» Articles » PMID: 26779761

Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids

Overview
Journal J Vis Exp
Date 2016 Jan 19
PMID 26779761
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional (3D) tumor spheroids are utilized in cancer research as a more accurate model of the in vivo tumor microenvironment, compared to traditional two-dimensional (2D) cell culture. The spheroid model is able to mimic the effects of cell-cell interaction, hypoxia and nutrient deprivation, and drug penetration. One characteristic of this model is the development of a necrotic core, surrounded by a ring of G1 arrested cells, with proliferating cells on the outer layers of the spheroid. Of interest in the cancer field is how different regions of the spheroid respond to drug therapies as well as genetic or environmental manipulation. We describe here the use of the fluorescence ubiquitination cell cycle indicator (FUCCI) system along with cytometry and image analysis using commercial software to characterize the cell cycle status of cells with respect to their position inside melanoma spheroids. These methods may be used to track changes in cell cycle status, gene/protein expression or cell viability in different sub-regions of tumor spheroids over time and under different conditions.

Citing Articles

Diffusion Smart-seq3 of breast cancer spheroids to explore spatial tumor biology and test evolutionary principles of tumor heterogeneity.

Cougnoux A, Mahmoud L, Johnsson P, Eroglu A, Gsell L, Rosenbauer J Sci Rep. 2025; 15(1):3811.

PMID: 39885179 PMC: 11782488. DOI: 10.1038/s41598-024-83989-x.


The Dual Luminescence Lifetime pH/Oxygen Sensor: Evaluation of Applicability for Intravital Analysis of 2D- and 3D-Cultivated Human Endometrial Mesenchymal Stromal Cells.

Litvinov I, Belyaeva T, Salova A, Aksenov N, Chelushkin P, Solomatina A Int J Mol Sci. 2023; 24(21).

PMID: 37958592 PMC: 10650141. DOI: 10.3390/ijms242115606.


3D melanoma spheroid model for the development of positronium biomarkers.

Karimi H, Moskal P, Zak A, Stepien E Sci Rep. 2023; 13(1):7648.

PMID: 37169794 PMC: 10175546. DOI: 10.1038/s41598-023-34571-4.


3D cancer models: One step closer to human studies.

Manduca N, Maccafeo E, De Maria R, Sistigu A, Musella M Front Immunol. 2023; 14:1175503.

PMID: 37114038 PMC: 10126361. DOI: 10.3389/fimmu.2023.1175503.


Applications and Advances of Multicellular Tumor Spheroids: Challenges in Their Development and Analysis.

Mitrakas A, Tsolou A, Didaskalou S, Karkaletsou L, Efstathiou C, Eftalitsidis E Int J Mol Sci. 2023; 24(8).

PMID: 37108113 PMC: 10138394. DOI: 10.3390/ijms24086949.


References
1.
Santini M, Rainaldi G . Three-dimensional spheroid model in tumor biology. Pathobiology. 1999; 67(3):148-57. DOI: 10.1159/000028065. View

2.
Desoize B, Jardillier J . Multicellular resistance: a paradigm for clinical resistance?. Crit Rev Oncol Hematol. 2000; 36(2-3):193-207. DOI: 10.1016/s1040-8428(00)00086-x. View

3.
Kyle A, Huxham L, Baker J, Burston H, Minchinton A . Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent. Cancer Res. 2003; 63(18):5707-11. View

4.
LaRue K, Khalil M, Freyer J . Microenvironmental regulation of proliferation in multicellular spheroids is mediated through differential expression of cyclin-dependent kinase inhibitors. Cancer Res. 2004; 64(5):1621-31. DOI: 10.1158/0008-5472.can-2902-2. View

5.
Kunz-Schughart L, Freyer J, Hofstaedter F, Ebner R . The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen. 2004; 9(4):273-85. DOI: 10.1177/1087057104265040. View